Early reduction of neurohumoral factors plays a key role in mediating the efficacy of β-blocker therapy for congestive heart failure
- 29 February 1996
- journal article
- clinical trial
- Published by Elsevier in American Heart Journal
- Vol. 131 (2) , 329-336
- https://doi.org/10.1016/s0002-8703(96)90362-2
Abstract
No abstract availableKeywords
This publication has 26 references indexed in Scilit:
- Beta-1-Selectivity Is Not Essential to Achieve Therapeutic Efficacy with Beta-Blockade Therapy for Idiopathic Dilated CardiomyopathyCardiology, 1995
- Beta-adrenergic receptor regulation and left ventricular function in idiopathic dilated cardiomyopathyThe American Journal of Cardiology, 1993
- Exercise hemodynamics and myocardial metabolism during long-term beta-adrenergic blockade in severe heart failureJournal of the American College of Cardiology, 1991
- Effects of bucindolol on neurohormonal activation in congestive heart failureThe American Journal of Cardiology, 1991
- Determination of beta adrenoceptor density on rabbit mononuclear leukocytesJournal of Pharmacological Methods, 1988
- Reversibility of Catecholamine-Induced Dilated Cardiomyopathy in a Child with a PheochromocytomaNew England Journal of Medicine, 1987
- Plasma Norepinephrine as a Guide to Prognosis in Patients with Chronic Congestive Heart FailureNew England Journal of Medicine, 1984
- The β-adrenergic receptor in human lymphocytes: Subclassification by the use of a new radio-ligand, (±)−125iodocyanopindololLife Sciences, 1981
- Effect of chronic beta-adrenergic receptor blockade in congestive cardiomyopathy.Heart, 1975
- THE ATTRACTIONS OF PROTEINS FOR SMALL MOLECULES AND IONSAnnals of the New York Academy of Sciences, 1949